Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$81.24 - $97.37 $49,881 - $59,785
614 Added 8.22%
8,088 $669,000
Q1 2024

Apr 15, 2024

BUY
$71.24 - $85.35 $268,289 - $321,428
3,766 Added 101.56%
7,474 $637,000
Q4 2023

Jan 16, 2024

SELL
$80.59 - $92.61 $433,654 - $498,334
-5,381 Reduced 59.2%
3,708 $317,000
Q3 2023

Oct 12, 2023

BUY
$82.56 - $93.49 $326,689 - $369,939
3,957 Added 77.1%
9,089 $814,000
Q2 2023

Aug 17, 2023

BUY
$80.84 - $89.45 $183,102 - $202,604
2,265 Added 79.0%
5,132 $436,000
Q1 2023

May 25, 2023

SELL
$72.75 - $90.6 $21,970 - $27,361
-302 Reduced 9.53%
2,867 $237,000
Q4 2022

Feb 01, 2023

BUY
$73.85 - $86.14 $234,030 - $272,977
3,169 New
3,169 $249,000
Q1 2018

Apr 19, 2018

SELL
$60.72 - $74.41 $802,961 - $983,997
-13,224 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$40.38 - $44.87 $533,985 - $593,360
13,224
13,224 $593,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.45B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.